Keywords: Norway, Market, Pharmaceuticals, Drug prices, Regulatory reform, Espicom

Reference pricing moderates pharmaceutical market in Norway

Article | 04 January 2011

The macroenvironment for the pharmaceutical industry in Norway is improving. Politically, the center-left coalition is expected to hold together for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in